NO20002167L - Anti-østrogen pluss progestin-inneholdende orale befruktningshindrende midler - Google Patents

Anti-østrogen pluss progestin-inneholdende orale befruktningshindrende midler

Info

Publication number
NO20002167L
NO20002167L NO20002167A NO20002167A NO20002167L NO 20002167 L NO20002167 L NO 20002167L NO 20002167 A NO20002167 A NO 20002167A NO 20002167 A NO20002167 A NO 20002167A NO 20002167 L NO20002167 L NO 20002167L
Authority
NO
Norway
Prior art keywords
oral contraceptives
containing oral
estrogen plus
plus progestin
progestin
Prior art date
Application number
NO20002167A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002167D0 (no
Inventor
Michael Jay Gast
Christopher Paul Miller
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NO20002167D0 publication Critical patent/NO20002167D0/no
Publication of NO20002167L publication Critical patent/NO20002167L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20002167A 1997-11-06 2000-04-27 Anti-østrogen pluss progestin-inneholdende orale befruktningshindrende midler NO20002167L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96508397A 1997-11-06 1997-11-06
PCT/US1998/023427 WO1999024027A2 (en) 1997-11-06 1998-11-04 Anti-estrogen plus progestin containing oral contraceptives

Publications (2)

Publication Number Publication Date
NO20002167D0 NO20002167D0 (no) 2000-04-27
NO20002167L true NO20002167L (no) 2000-06-28

Family

ID=25509417

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002167A NO20002167L (no) 1997-11-06 2000-04-27 Anti-østrogen pluss progestin-inneholdende orale befruktningshindrende midler

Country Status (28)

Country Link
EP (1) EP1051179B1 (de)
JP (1) JP2001522798A (de)
CN (1) CN1278732A (de)
AR (1) AR016667A1 (de)
AT (1) ATE304359T1 (de)
AU (2) AU760540B2 (de)
BG (1) BG104451A (de)
BR (1) BR9813982A (de)
CA (1) CA2307210A1 (de)
CZ (1) CZ294155B6 (de)
DE (1) DE69831605T2 (de)
DK (1) DK1051179T3 (de)
EA (1) EA200000492A1 (de)
EE (1) EE04092B1 (de)
ES (1) ES2246541T3 (de)
GE (1) GEP20043290B (de)
HR (1) HRP20000269A2 (de)
HU (1) HUP0100293A3 (de)
ID (1) ID24568A (de)
IL (1) IL135621A0 (de)
NO (1) NO20002167L (de)
NZ (1) NZ503890A (de)
PL (1) PL340623A1 (de)
SK (1) SK6482000A3 (de)
TR (1) TR200001268T2 (de)
UA (1) UA68365C2 (de)
WO (1) WO1999024027A2 (de)
ZA (1) ZA9810136B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
EA005932B1 (ru) * 1998-05-15 2005-08-25 Уайт 2-фенил-1-[4-(2-аминоэтокси)бензил]индол в комбинации с эстрогенами
US6380166B1 (en) 1999-09-13 2002-04-30 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
CA2382683A1 (en) * 1999-09-13 2001-03-22 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-¬4-(2-amin-1-yl-ethoxy)-benzyl|-1h-indol-5-ols
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
JP2005504032A (ja) 2001-07-31 2005-02-10 ファイザー・プロダクツ・インク エストロゲン・アゴニスト／アンタゴニスト、エストロゲン及びプロゲスチンの組み合わせを含む医薬組成物、キット及び方法
SI1809602T1 (sl) 2004-10-27 2009-04-30 Janssen Pharmaceutica Nv Indolni derivati, uporabni kot modulatorji progesteronskega receptorja
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
UY29527A1 (es) 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
DE102008057230A1 (de) * 2008-11-11 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin
RS56042B1 (sr) 2010-06-10 2017-09-29 Seragon Pharmaceuticals Inc Modulatori estrogenih receptora i njihove upotrebe
WO2013090829A1 (en) 2011-12-14 2013-06-20 Aragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
KR20240142622A (ko) 2015-10-01 2024-09-30 올레마 파마슈티컬스 인코포레이티드 테트라히드로-1H-피리도[3,4-b]인돌 항에스트로겐 약물
LT3386500T (lt) 2015-12-09 2022-12-27 The Board Of Trustees Of The University Of Illinois Selektyvūs estrogenų receptorių slopintojai benzotiofeno pagrindu
ES2990061T3 (es) 2016-05-10 2024-11-28 C4 Therapeutics Inc Degronímeros espirocíclicos para la degradación de proteínas diana
CN109641874A (zh) 2016-05-10 2019-04-16 C4医药公司 用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
EP3454856B1 (de) 2016-05-10 2024-09-11 C4 Therapeutics, Inc. Heterocyclische degronimere für zielproteinabbau
CN109790143A (zh) 2016-05-10 2019-05-21 C4医药公司 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
RU2019102647A (ru) 2016-07-01 2020-08-03 Г1 Терапьютикс, Инк. Антипролиферационные средства на основе пиримидина
WO2018081168A2 (en) 2016-10-24 2018-05-03 The Board Of Trustees Of The University Of Illinois Benzothiophene-based selective mixed estrogen receptor downregulators
MX2019008158A (es) 2017-01-06 2019-12-09 G1 Therapeutics Inc Terapia de combinacion para el tratamiento del cancer.
KR20190117582A (ko) 2017-02-10 2019-10-16 쥐원 쎄라퓨틱스, 인크. 벤조티오펜 에스트로겐 수용체 조정제
CN110769822A (zh) 2017-06-20 2020-02-07 C4医药公司 用于蛋白降解的n/o-连接的降解决定子和降解决定子体
WO2019006393A1 (en) 2017-06-29 2019-01-03 G1 Therapeutics, Inc. Morphic forms of git38 and methods of manufacture thereof
CN120698983A (zh) 2018-12-20 2025-09-26 C4医药公司 靶向蛋白降解
KR20220034129A (ko) 2019-07-07 2022-03-17 올레마 파마슈티컬스 인코포레이티드 에스트로겐 수용체 길항제 요법
KR20220119415A (ko) 2019-12-20 2022-08-29 씨4 테라퓨틱스, 인코포레이티드 Egfr 분해를 위한 이소인돌리논 및 인다졸 화합물
TW202146412A (zh) 2020-03-05 2021-12-16 美商Ｃ４醫藥公司 用於標靶降解brd9之化合物
IL300397A (en) 2020-08-05 2023-04-01 C4 Therapeutics Inc Compounds for targeted knockdown of RET
MX2023014059A (es) 2021-06-08 2024-03-12 C4 Therapeutics Inc Terapeuticos para la degradacion de una proteina quiinasa de serina/ treonina mutante.
WO2024030968A1 (en) 2022-08-03 2024-02-08 Brystol-Myers Squibb Company Compounds for modulating ret protein
EP4611901A1 (de) 2022-11-04 2025-09-10 Bristol-Myers Squibb Company Ret-ldd-protein-abbauer
WO2024097980A1 (en) 2022-11-04 2024-05-10 Bristol-Myers Squibb Company Ret-ldd protein inhibitors
EP4735452A2 (de) 2023-06-30 2026-05-06 Merck Patent GmbH Heterobifunktionelle verbindungen zum abbau des kras-proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA716118B (en) * 1970-10-05 1972-05-31 Richardson Merrell Inc Contraception
ZA9510926B (en) * 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
IL120266A (en) * 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
PT802183E (pt) * 1996-04-19 2002-03-28 American Home Prod Agentes estrogenicos
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive

Also Published As

Publication number Publication date
CZ294155B6 (cs) 2004-10-13
NZ503890A (en) 2002-08-28
CN1278732A (zh) 2001-01-03
SK6482000A3 (en) 2000-11-07
AU760540B2 (en) 2003-05-15
DK1051179T3 (da) 2005-10-31
EE200000211A (et) 2001-04-16
WO1999024027A2 (en) 1999-05-20
WO1999024027A3 (en) 1999-07-15
ES2246541T3 (es) 2006-02-16
ID24568A (id) 2000-07-27
EA200000492A1 (ru) 2000-10-30
GEP20043290B (en) 2004-07-26
EP1051179A2 (de) 2000-11-15
HRP20000269A2 (en) 2000-12-31
AR016667A1 (es) 2001-07-25
ATE304359T1 (de) 2005-09-15
IL135621A0 (en) 2001-05-20
AU1303199A (en) 1999-05-31
AU2003204896B2 (en) 2006-06-15
DE69831605T2 (de) 2006-06-14
EE04092B1 (et) 2003-08-15
HUP0100293A3 (en) 2002-12-28
JP2001522798A (ja) 2001-11-20
ZA9810136B (en) 2000-05-05
HUP0100293A2 (hu) 2001-10-28
BG104451A (en) 2000-12-29
TR200001268T2 (tr) 2001-01-22
EP1051179B1 (de) 2005-09-14
DE69831605D1 (de) 2005-10-20
CA2307210A1 (en) 1999-05-20
UA68365C2 (en) 2004-08-16
BR9813982A (pt) 2000-09-26
NO20002167D0 (no) 2000-04-27
PL340623A1 (en) 2001-02-12
CZ20001661A3 (cs) 2000-12-13

Similar Documents

Publication Publication Date Title
DK1051179T3 (da) Anti-estrogen- plus progestin-holdige orale kontraceptiva
ID20233A (id) Komposisi oral
DE59802860D1 (de) Desinfektionsmittel
EP1072253A4 (de) Oral zu verabreichende zubereitungen
DE59506139D1 (de) Orale Retard-Präparation
MA24473A1 (fr) Formulations
DE59802830D1 (de) Orthesengelenk
NO993096D0 (no) Orale cyklosporinformuleringer
EP0836470A4 (de) Orale zusammensetzungen
DE60007530D1 (de) Oral wirksame androgene
DE69827710D1 (de) Kippbecken-WC
ATE218540T1 (de) Mikrobiozide n-sulfonylglycin- alkynyloxyphenethylamid-derivate
ITMI991826A0 (it) Nuova formulazione orale
ATE348582T1 (de) Kondom
DK1334725T3 (da) Östroprogestativt antikonceptionsmiddel
DE69821845D1 (de) Ostomievorrichtung
ID20466A (id) Komposisi oral
ID19885A (id) Tisu lembab
DE69907677D1 (de) Brennstoff-luft-mischgerät
DK0853933T3 (da) Ostomikobling
DE69832127D1 (de) Wässrige Siliconzusammensetzung
ID20328A (id) Toilet
EP0998924A4 (de) Antitumor-wirkstoffe
DE69804179D1 (de) Photoempfindliche Zusammensetzung
DE59702106D1 (de) Knabber

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application